Analysis: The government is expanding access to ADHD diagnosis, but experts warn medication alone won't fix NZ's systemic ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

A new study from Finland has found that children with attention-deficit/hyperactivity disorder often stay on medication for ...

Researchers reviewing nearly 300 top-tier ADHD drug trials found that half skipped the rigorous, expert-led evaluations needed to rule out other conditions like depression or schizophrenia. With ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants to treat ...

Collegium's new ADHD drugs may allow the company to grow revenues faster and pay off debt faster. Click here to find out why ...

The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit ...

Telehealth prescribing of stimulants for teens and adults with ADHD is not linked to a higher risk for substance use disorder vs in-person prescribing, a new study shows.

Children younger than 6 years of age who are prescribed extended-release stimulants for attention-deficit hyperactivity disorder (ADHD) may experience ...

New Zealanders with attention-deficit hyperactivity disorder (ADHD) will now have easier access to diagnosis and medication after the government ...

As ADHD medication use has surged in Sweden over the past decades, evidence is needed on whether the benefit of the ...

The FDA now requires updated labeling for all extended-release stimulant medications used to treat attention deficit hyperactivity disorder, warning of increased risk of weight loss and other side ...